The reduction in average number of eye drops per patient was also significant. On average, there was a reduction of 1 to 2 eye drops per patient during the follow-up period, reaching approximately 70% of patients without the need of glaucoma eye drops at the end of 6 months. (5) MIGS will be increasingly used in Brazil both by glaucoma surgeons and cataract surgeons, thus allowing to increase the options of the surgical treatment of open-angle glaucoma to the earliest stages of the disease. This will allow for a paradigm shift in the treatment of glaucoma, and perhaps help preventing glaucoma from progressing to more advanced stages. It is expected that a more effective blood pressure control (with surgery) earlier in the history of the disease can prevent more serious cases in the future, thus avoiding the need of more invasive and riskier surgeries. In addition to robust clinical evidence and speculation about the impact of using MIGS for glaucoma progression in the future, there is data available suggesting that the use of MIGS would be more cost-effective. A study carried out in Colombia showed that iStent use in surgeries combined with cataract (related to the use of Timolol Maleate 0.5% eye drops, when needed) was the most cost-effective alternative compared to laser trabeculoplasty or different prostaglandins (associated with the use of a fixed combination of Timolol Maleate 0.5% and Dorzolamide Hydrochloride 2%, when needed). (6) Another study carried out in Canada compared the use of iStent Inject (isolated use without being associated with cataract surgery) to the use of different combinations of medications for the treatment of open-angle glaucoma. (7) In said study, iStent Inject was the most costeffective and fully dominated alternative, that is, the cheapest and the most effective from the perspective of the public health system and in a period of 15 years. (7) The device was only completely dominated from the 4th year follow-up. Before that, the device was not cost-effective. (7) Studies like these show the true impact that this type of surgery can have, not only for the individual but also for the community and health systems, avoiding direct medical costs, direct non-medical costs, and future indirect costs.
Given what MIGS offers and what the results attest, there is room for these techniques to be used safely and effectively. Therefore, it is worth going deeper on the theoretical and practical knowledge of these innovative surgical techniques.
